SPS
BVS icon

Susquehanna Portfolio Strategies’s Bioventus BVS Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,344
Closed -$82.5K – 371
2024
Q2 		$82.5K Sell
14,344
-18,750
-57% -$103K ﹤0.01% 488
2024
Q1 		$172K Hold
33,094
– – ﹤0.01% 746
2023
Q4 		$174K Buy
+33,094
New +$131K ﹤0.01% 951

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna Portfolio Strategies's BVS Position: Q3 2024 in Review

Susquehanna Portfolio Strategies sold out of Bioventus (BVS) in Q3 2024, closing a stake of 14,344 shares — an estimated $82.5K sold.

Susquehanna Portfolio Strategies first reported a position in BVS in Q4 2023 and held it in 3 quarters. The position peaked at $174K in Q4 2023. 138 funds tracked by Wall St. Rank hold BVS as of Q3 2024.

  • Susquehanna Portfolio Strategies reported no remaining Bioventus position as of Q3 2024 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 14,344 Bioventus shares in Q3 2024, an estimated $82.5K.
  • Susquehanna Portfolio Strategies first reported a position in Bioventus in Q4 2023 and held it in 3 quarters.
  • Susquehanna Portfolio Strategies's Bioventus position peaked at $174K in Q4 2023.
  • 138 funds tracked by Wall St. Rank held Bioventus as of Q3 2024.

Based on Susquehanna Portfolio Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.